FDA clears Agilent cancer diagnostic for four tumor types

July 14, 2026 8:00 AM

Agilent Technologies (NYSE: A) has received U.S. Food and Drug Administration approval for its PD-L1 IHC 28-8 pharmDx assay as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found